What is ALR Technologies Inc. (ALRTF) stock price today?

ALR Technologies Inc. (ALRTF) is currently trading at $0.02, up 0% today.

What is ALRTF P/E ratio?

ALR Technologies Inc.'s P/E ratio is -1.35. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is ALRTF return on equity (ROE)?

ALR Technologies Inc.'s return on equity (ROE) is 51.64%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is ALR Technologies Inc.'s market cap?

ALR Technologies Inc. has a market capitalization of $11.64M.

OTC · Medical - Devices

ALR Technologies Inc. (ALRTF) Stock

$0.02 +0.00% OTC: ALRTF Healthcare

ALR Technologies Inc. is a data management company dedicated to creating and providing diabetes care solutions for both human and animal health sectors across the United States.

Valuation

Metric	Value
Price	$0.02
Market Cap	$11.64M
P/E Ratio	-1.35
P/B Ratio	-0.66
P/S Ratio	0.00
EPS (TTM)	$-0.02
52-Week High	$0.03
52-Week Low	$0.01
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	51.64%
ROA	—
ROCE	12.12%
Gross Margin	66.22%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-0.79
Current Ratio	0.01

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-1.0M	$-2.0M	$-4.0M	$-4.0M	$-3.0M
Net Profit	$-3.0M	$-4.0M	$-9.0M	$-6.0M	$-12.0M
EPS	$-0.01	$-0.02	$-0.04	$-0.02	$-0.02
Op Margin	—	—	—	—	-39448.3%

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$0	$0	$0	$0	$0
Total Liabilities	$26.0M	$28.0M	$31.0M	$22.0M	$25.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$21.0M	$23.0M	$25.0M	$17.0M	$19.0M

Latest News

ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares PR Newswire · Jun 30, 2026 ALR TECHNOLOGIES HAS LAUNCHED THE GLUCURVE PET CGM IN CANADA PR Newswire · May 19, 2026

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$-1.0M	$-1.0M	$-1.0M	$-1.0M	$-2.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$1.0M	$1.0M	$1.0M	$1.0M	$2.0M
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-1.0M	$-1.0M	$-1.0M	$-1.0M	$-2.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.04
EV / EBITDA	-1.96
FCF Yield	-17.19%
Quick Ratio	0.01
Interest Coverage	-1.44
Return 1Y	80.30%
Return 3Y	-51.27%
Return 5Y	—

Ownership

Insiders Held60.26%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$336.64	-1.11%	38.93	$4.94T	0.32%
MSFTMicrosoft Corporation	$535.07	+2.38%	28.68	$3.97T	0.76%
GOOGLAlphabet Inc.	$351.66	+0.97%	16.94	$4.26T	0.26%
AMZNAmazon.com, Inc.	$262.43	+3.29%	19.82	$2.82T	0.00%
METAMeta Platforms, Inc.	$718.67	-0.31%	27.93	$1.83T	0.28%

About ALR Technologies Inc.

ALR Technologies Inc. is a data management company dedicated to creating and providing diabetes care solutions for both human and animal health sectors across the United States. Central to its offerings is the comprehensive Diabetes Management System. This system facilitates data collection, provides predictive A1C analysis, offers recommendations for insulin dosage adjustments, tracks performance, enables remote patient monitoring, and supplies essential diabetes testing materials. The company also markets Continuous Glucose Monitoring (CGM) devices, which are wearable medical technologies designed to provide continuous blood sugar readings. Addressing a specific need in veterinary medicine, ALR Technologies offers the GluCurve Pet CGM, tailored for diabetic felines and canines, and utilized by veterinarians. Furthermore, their Prediabetes System supports patients with educational video content, supplementary resources optimized for mobile devices, and a private online community for discussing disease management strategies. ALR Technologies primarily serves healthcare providers, health insurance companies, and entities specializing in disease and case management services, including those within the home care industry. Originally incorporated in 1987 as Mo Betta Corp., the company rebranded to ALR Technologies Inc. in December 1998. It is based in Richmond, Virginia, and operates as a subsidiary of ALR Technologies SG Ltd.

ALR Technologies Inc. is headquartered in SG.

ALR Technologies Inc. (ALRTF) stock trades at $0.02 with a market capitalization of $11.64M. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.35, reflecting a net loss over the last twelve months, a negative price-to-book of -0.66, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.03, and currently trades 33.3% below its 52-week high.

On profitability, ALR Technologies Inc. generates a return on equity (ROE) of 51.64% (not meaningful, as shareholders' equity is negative), return on capital employed of 12.12%.

Official website: www.alrt.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.